National Health Investors (NYSE:NHI) Posts Quarterly Earnings Results, Misses Expectations By $0.19 EPS

Share on StockTwits

National Health Investors (NYSE:NHI) posted its quarterly earnings data on Sunday. The real estate investment trust reported $0.82 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.01 by ($0.19), Fidelity Earnings reports. The company had revenue of $81.24 million for the quarter, compared to analysts’ expectations of $84.22 million. National Health Investors had a net margin of 56.94% and a return on equity of 12.64%. The business’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same quarter last year, the business posted $1.41 EPS.

NHI stock opened at $69.79 on Tuesday. The firm’s 50-day moving average price is $67.43 and its two-hundred day moving average price is $64.50. National Health Investors has a 12-month low of $31.37 and a 12-month high of $91.12. The stock has a market capitalization of $3.12 billion, a price-to-earnings ratio of 16.38 and a beta of 0.88. The company has a current ratio of 13.13, a quick ratio of 13.13 and a debt-to-equity ratio of 1.02.

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 29th. Shareholders of record on Thursday, December 31st were given a $1.102 dividend. This represents a $4.41 dividend on an annualized basis and a dividend yield of 6.32%. The ex-dividend date of this dividend was Wednesday, December 30th. National Health Investors’s payout ratio is 80.18%.

In other news, Director Robert G. Adams acquired 2,000 shares of the firm’s stock in a transaction on Monday, December 14th. The shares were purchased at an average price of $67.75 per share, for a total transaction of $135,500.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 5.74% of the stock is currently owned by insiders.

Several research firms have recently weighed in on NHI. Mizuho cut shares of National Health Investors from a “neutral” rating to an “underperform” rating and lowered their price objective for the company from $56.00 to $55.00 in a research report on Wednesday, January 13th. BMO Capital Markets cut shares of National Health Investors from a “market perform” rating to an “underperform” rating and set a $68.00 target price on the stock. in a research report on Thursday, January 7th. KeyCorp upgraded shares of National Health Investors from an “underweight” rating to a “sector weight” rating in a research report on Monday, December 14th. Zacks Investment Research cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Thursday, January 14th. Finally, Berenberg Bank cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Wednesday, December 2nd. Two equities research analysts have rated the stock with a sell rating and seven have given a hold rating to the company. National Health Investors has an average rating of “Hold” and an average price target of $61.57.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Featured Story: Dual Listing What You Need to Know

Earnings History for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with's FREE daily email newsletter.